Week beginning 15th April 2024
News, advocacy and media
Trial by Error by David Tuller
Senator Bernie Sanders' $10 Billion Long Covid "Moonshot" Proposal
On the work to ensure that ME/CFS and patients who got sick with ME/CFS before the pandemic, will be included in the research program of Bernie Sanders' Long Covid Moonshot proposal. Includes a letter to Sanders from Todd Davenport urging the inclusion of people with ME/CFS and other infection-associated chronic conditions in the legislation for Long Covid funding.
Article l
Thread
An Interview with the Authors of the European ME Alliance Survey of 11.000+ Patients
David Tuller interviews the authors behind the recent EMEA report "Same disease different approaches and experiences" which is based on a survey of ME/CFS patients in Europe. The authors are Arild Angelsen, a board member of the Norwegian ME Association and a professor at the School of Economics and Business at Norwegian University of Life Sciences, and Trude Schei, assistant secretary general of the Norwegian ME Association.
Interview l
Thread
Guardian Columnist George Monbiot Discusses His Scathing Critique of the "Biopsychosocial" Approach to ME/CFS and Long Covid
Excellent conversation between Tuller and the investigative journalist and political activist George Monbiot diving into several serious aspects with the so-called "biopsychosocial" approach including the role of the Science Media Centre.
Interview l
Thread
The Times Parents accused of faking their children's long Covid
"Medical ignorance is leading to parents of children with long Covid being reported to social services in an echo of the way professionals dismissed ME, doctors warn".
Thread with article
Podcast ME/CFS: What's in a name? (A lot, actually)
A very well researched podcast episode on ME from This Podcast Will Kill You. "In this episode, we dig into what we know and what we hypothesize about the biological underpinnings of ME/CFS before tracing the twisty history of this disease, as popular perception switched back and forth and back again from “real” to “imagined” disease."
Podcast l
Thread
Medscape 4 Years In, a Sobering Look at Long COVID Progress
On the slow progress for scientific progress for Long Covid. Researcher Al-Aly expresses concern about the chronic nature of Long Covid and says the NIH needs to get its act together and to do more.
Article l
Thread
Cochrane have sent a brief response to the latest Science for ME committee letter in which we presented the petition and explained why the 2019 review, Exercise therapy for CFS, should be withdrawn on the grounds of harms.
"We will include the additional points and references to studies in our review of the issues raised by S4ME in previous correspondence... some of the questions will be addressed on the Cochrane project website."
There have been no monthly updates on the new review since December 2023.
S4ME letter |
Cochrane reply |
Petition |
Thread
.............
Research news and commentary
Australia NCNED at Griffith University secures $438,000 grant
The grant was awarded by ME Research UK and will track brain changes through ME/CFS using a 7 Tesla MRI. It is anticipated to detect subtle brain changes not evident with currently available clinical imaging.
Announcement |
Thread
European Research Council
Professor Ruth Ley has received an Advanced Grant from the European Research Council. This funding will enable Ley and her team to investigate how flagellins produced by beneficial gut bacteria interact with the human immune system. Silent flagellin is linked to chronic inflammatory diseases, including myalgic encephalomyelitis (ME).
Article |
Thread
JMIR Research Protocols
Personalized Management of Fatigue in Individuals With ME/CFS and Long COVID Using a Smart Digital mHealth Solution: Protocol for a Participatory Design Approach - Dorronzoro-Zubiete et al.
This is the study protocol for the MyFatigue project which aims address fatigue in ME/CFS and long COVID through the development of digital mobile health solutions for self-management and predict perceived fatigue severity using real-time data.
Article |
Thread
Prusty Lab
Prusty Lab, the laboratorium and team of ME/CFS researcher Bhupesh Prusty has a new website. Prusty is currently Professor of Science at Rīga Stradiņš University in Latvia.
Website |
Thread
.............
Coming events
USA NIH ME/CFS symposium
Thursday, May 2, 2024, 9:00:00 AM, Eastern Time, Washington DC Local
Author: Dr. Brian Walitt. Runtime: 7 hours
The purpose of the conference is to present findings from the study and the article "Deep phenotyping of post-infectious ME/CFS" to the ME/CFS community. The event is timed to coincide with publication of the article in Nature magazine.
You will be able to view this event at
https://videocast.nih.gov/ on the day of the event.
Details |
Thread
UK Clinical Research Collaboration workshops
"...a series of online workshops on clinical research in ME/CFS. The workshops are connected with the Research Working Group set up by the UK Clinical Research Collaboration. The workshops aim to raise the profile of ME/CFS clinical research, increase collaboration, attract new researchers and formulate research priorities in this area of huge unmet need."
1. Clinical Trial Design in People with ME/CFS, 4th June 2024
Details |
Thread
2. Clinical Trial Platform Studies and Lessons for ME/CFS research, 6th June
Details |
Thread
3. Drug Repurposing Clinical Trials in People with ME/CFS, 26th June
Details |
Thread
4. ME/CFS Research and Underserved Groups, 16th July
Details |
Thread
...........
Research
ME/CFS and related research
Public Health Reviews
An Unwanted but Long-Known Company: Post-Viral Symptoms in the Context of Past Pandemics in Switzerland (and Beyond) - Staub et al.
This article summarises the literature on post-viral symptoms during past pandemics and supplements and illustrates it with Swiss examples from the pandemics of 1890, 1918–1920 and later.
Article |
Thread
The Qualitative Report
Exploring the Experience of Healthcare-Related Epistemic Injustice among People with ME/CFS - Hunt et al.
Interviews were conducted with 5 people with ME/CFS in the UK regarding healthcare-related epistemic injustice.
Article |
Thread
Long Covid research
Brain, Behavior, and Immunity
Neuroinflammation in post-acute sequelae of COVID-19 (PASC) as assessed by [11C]PBR28 PET correlates with vascular disease measures — VanElzakker et al.
"We used [11C]PBR28 PET neuroimaging, a marker of neuroinflammation, to compare 12 PASC individuals versus 43 normative healthy controls. We found significantly increased neuroinflammation in PASC versus controls across a wide swath of brain regions"
Article |
Thread
Nature Scientific Reports
Recovery of neurophysiological measures in post-COVID fatigue: a 12-month longitudinal follow-up study — Maffitt et al.
"as the pCF cohort recovered from the symptoms of fatigue, their twitch tension rise times became faster than controls. This suggests that the improvement over time in muscle fatigability (corresponding to an improved ability of muscle to generate force with continued contraction) might be due partly to a process of adaptation rather than a complete return to baseline physiology."
Article |
Thread
Journal of Inflammation Research
Long COVID-19 and Peripheral Serotonin: A Commentary and Reconsideration — George M Anderson et al.
"the role (or roles) of 5-HT in acute and long COVID remains very much an open question. Wong et al hypothesize that problems arise from too little peripheral 5-HT. However, given the frequent presence of a hyperaggregation state in long COVID, and the known augmenting effects of platelet 5-HT on platelet aggregation, it is also plausible to suggest that reductions in platelet 5-HT could be beneficial."
Article |
Thread
Gastroenterology
Clearance of gut mucosal SARS-CoV-2 antigens and post-acute COVID-19 after two years in patients with inflammatory bowel disease — Andreas Zollner et al.
"The window of gut mucosal antigen clearance (months to years) suggests that stem cells in the gut or bone marrow are affected, because most gut-resident immune cells exhibit a half-life of days to weeks. As such, our study indicates that viral antigen clearance is associated with resolution of symptoms and serum serotonin restoration in post-acute COVID-19."
Article |
Thread
Pharmacological Research
SARS-CoV-2 Mitochondrial Metabolic and Epigenomic Reprogramming in COVID-19 — Guarnieri et al.
"To determine the effects of SARS-CoV-2 infection on cellular metabolism, we conducted an exhaustive survey of the cellular metabolic pathways modulated by SARS-CoV-2 infection"
Article |
Thread
BMC Medicine
What is quality in long covid care? Lessons from a national quality improvement collaborative and multi-site ethnography — Greenhalgh et al.
"The original aim of this study—to examine the nature of quality in long covid care and reduce unwarranted variation in services—evolved to focus on examining the reasons why standardizing care was so challenging in this condition."
Article |
Thread
PNAS Nexus
Host–microbiome associations in saliva predict COVID-19 severity — Alqedari et al.
"While this study offers preliminary biomarker results, it is important to consider that the salivary microbiome is only one of many factors that could influence the course of COVID-19"
Article |
Thread
Nature Communications
Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection — Phetsouphanh et al.
"This study investigates the humoral and cellular immune responses and health-related quality of life measures in individuals with mild to moderate long COVID (LC) compared to age and gender matched recovered COVID-19 controls (MC) over 24 months."
Article |
Thread
Neurology Neuroimmunology & Neuroinflammation
Case-Control Study of Individuals With Small Fiber Neuropathy After COVID-19 — McAlpine et al.
"Here, we present preliminary evidence that after COVID-19, SFN is responsive to treatment with IVIG and linked with neurovascular dysregulation and dysautonomia on [invasive cardiopulmonary exercise testing]. "
Article |
Thread
Annual Review of Virology
The Spectrum Of Postacute Sequelae Of Covid-19 In Children: From MIS-C To Long Covid — Abigail S. Kane et al.
"Shared pathophysiologic mechanisms suggest long covid is a more indolent version of MIS-C"
Article |
Thread
Preprint: BioRxiv
Antibody-mediated cellular responses are dysregulated in Multisystem Inflammatory Syndrome in Children (MIS-C) — Jenna K Dick et al.
"while it is likely that multiple pathogenic mechanisms contribute to MIS-C, our data suggest an imbalance of the antibody-mediated cellular response as a mechanistic correlate of this rare, but life-threatening, outcome of SARS-CoV-2 infection in children."
Article |
Thread
............
S4ME social media:
Forum,
Facebook,
Twitter,
Mastodon and
YouTube